Stay updated on Lemzoparlimab Combination in MDS Clinical Trial
Sign up to get notified when there's something new on the Lemzoparlimab Combination in MDS Clinical Trial page.

Latest updates to the Lemzoparlimab Combination in MDS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew revision entry 'Revision: v3.3.3' was added to the record history, and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. These changes are administrative in nature and do not affect study details or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRecord History now shows Revision: v3.3.2 added and Revision: v3.2.0 removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the site-wide notice about government funding and the NIH Clinical Center's operating status.SummaryDifference0.8%

- Check58 days agoChange DetectedVersions show changes to recruitment status and study status. Later updates include study design and sponsor/collaborators.SummaryDifference0.1%

- Check87 days agoChange Detected- Added a prominent notice about potential service delays due to funding lapse and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0. - Removed reference to v3.1.0.SummaryDifference13%

- Check94 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Lemzoparlimab Combination in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lemzoparlimab Combination in MDS Clinical Trial page.